FDA
-
-
-
-
-
-
-
FDA approves Lilly's Inluriyo combo with Verzenio for breast cancer
-
-
-
-
-
-
-
FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes
-
-
-
-
-
-
-
Lilly reports second-quarter 2026 financial results, raises full-year guidance, and highlights continued growth and pipeline progress
-
-
-
-
-
-
-
Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions
-
-
-
-
-
-
-
A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity
-
-
-
-
-
-
-
International Regulatory Pathways Have Supported Drug Development Across Biotech and Pharma
-
-
-
-
-
-
-
Lilly's oral diabetes drug outperforms rival in late-stage trials
-
332,015 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

